FollowTheFilings
Managers
Activity
Compare
Newest
Investment
PROTALIX BIOTHERAPEUTICS INC
Historical 13F holders
CUSIP
74365A309
Type
Equity
Class
COM
Period
13F filings
2026 Q1
3
2025 Q4
5
2025 Q3
4
2025 Q2
4
2025 Q1
6
2024 Q4
5
2024 Q3
5